SOLENO THERAPEUTICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Soleno Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q2 2024.
  • Soleno Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.9M, a 158% decline year-over-year.
  • Soleno Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$65.4M, a 130% decline year-over-year.
  • Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$39M, a 62% decline from 2022.
  • Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$24.1M, a 22.1% increase from 2021.
  • Soleno Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.9M, a 25.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$65.4M -$21.9M -$13.4M -158% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$52M -$21.4M -$13M -156% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$39M -$11.3M -$5.81M -106% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$33.2M -$10.9M -$4.73M -77.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$28.4M -$8.48M -$1.75M -26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$26.7M -$8.36M -$2.63M -46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$24.1M -$5.49M -$2.66M -94% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$21.4M -$6.13M +$2.01M +24.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$23.4M -$6.73M +$4.26M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$27.7M -$5.72M +$3.23M +36.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$30.9M -$2.83M +$24K +0.84% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$30.9M -$8.14M +$405K +4.74% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$31.3M -$11M -$3.6M -48.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$27.7M -$8.95M -$3.1M -52.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$24.6M -$2.85M +$11.8M +80.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$36.4M -$8.55M -$9.43M -1061% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$27M -$7.38M +$2.62M +26.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$29.6M -$5.86M +$1.17M +16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$30.8M -$14.6M -$14.9M -5661% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$15.9M $889K +$3.63M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$19.5M -$10M -$2.95M -41.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$16.6M -$7.03M -$3.23M -84.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$13.3M $263K +$5.01M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$18.3M -$2.74M +$1.05M +27.7% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-18
Q2 2018 -$19.4M -$7.06M -$3.09M -77.8% Apr 1, 2018 Jun 30, 2018 10-Q/A 2019-11-18
Q1 2018 -$16.3M -$3.8M -$917K -31.8% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-11-18
Q4 2017 -$15.4M -$4.74M -$2.13M -81.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-20
Q3 2017 -$13.3M -$3.79M -$1.04M -37.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$12.2M -$3.97M -$456K -13% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$11.8M -$2.89M +$302K +9.47% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$12.1M -$2.61M +$232K +8.17% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$12.3M -$2.75M +$543K +16.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$12.8M -$3.51M -$5.39M -287% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$7.45M -$3.19M +$8.46M +72.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$15.9M -$2.85M +$4.37M +60.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$20.3M -$3.29M -$900K -37.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$19.4M $1.88M +$4.67M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$24.1M -$11.7M -$10.8M -1297% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-08-09
Q4 2014 -$13.2M -$7.22M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$2.39M -$803K -50.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.79M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$834K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q3 2013 -$1.59M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.